Providence Therapeutics
Business Services · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
120-8832 Blackfoot Trl SE, Calgary, Albe...Revenue
$6.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
2
1
1
About Providence Therapeutics
Providence Therapeutics is a Canadian clinical-stage biotechnology company specializing in the development of mRNA vaccines and therapeutics aimed at treating cancer and infectious diseases. With operations in Calgary and Toronto, the company offers a robust ecosystem for the rapid development of mRNA-based solutions. Their platform technology is designed for collaboration with industry players, scientific communities, and academia to advance therapeutic developments. The executive team comprises experts with extensive experience in RNA therapeutics, positioning Providence as a leader in the biotech field.Explore more
Providence Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Providence Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Providence Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Click to see if Providence Therapeutics had a recent Job posting/layoffs
Check out if Providence Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Providence Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Providence Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Providence Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Providence Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Providence Therapeutics launches new products
Recommended Actions
Find VP level buyers at Providence Therapeutics
Find 3 more new buyers
Compare Similar Companies to Providence Therapeutics
Compare insights from companies similar to Providence Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Providence Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Providence Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Providence Therapeutics.
Providence Therapeutics financials insights
Gather financial insights about Providence Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Grant
$2.1M
Providence Therapeutics Tech Stack
A closer look at the technologies used by Providence Therapeutics
Most Recent Scoops
Event
Product Marketing, Events, Sales, Laboratory Operations, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Operations
Event
Product Marketing, Events, Sales, Laboratory Operations, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Operations
Open Position
Open Position
Open Position
Providence Therapeutics News & Media
Providence Therapeutics Announces World-First Personalized Pediatric mRNA Cancer Vaccine Trial
Landmark Australian study opens new possibilities for children with aggressive brain tumors and signals opportunity for Canada and USA. CALGARY, AB and BRISBANE, Australia , Feb. 5, 2026 /PRNewswire/ -- Providence Therapeutics, a Canadian clinical-stage mRNA biotechnology company, is supporting a world-first clinical trial evaluating personalized mRNA cancer vaccines for children with advanced and treatment-resistant brain tumors. The PaedNEO-VAX trial, funded by Providence Therapeutics, in combProvidence and Ontario Institute for Cancer Research (OICR) partnering to discover and develop mRNA therapeutics
CALGARY, AB and TORONTO, May 23, 2024 /PRNewswire/ -- Providence Therapeutic Holdings Inc. ("Providence"), a messenger RNA (mRNA) and lipid nanoparticle platform company engaged in the development of vaccines and therapeutics, and the Ontario Institute for Cancer Research (OICR), Ontario's largest publicly funded cancer research institute delivering real-world solutions to people affected by cancer, today announced the signing of a collaboration agreement for mRNA drug discovery and development.Providence Therapeutics Announces Partnership with University Health Network (UHN) for mRNA Therapeutic Discovery and Development
CALGARY, Alberta, June 02, 2023 (GLOBE NEWSWIRE) -- Providence Therapeutics Holdings Inc. ("Providence"), a biopharmaceutical company developing messenger RNA (mRNA) vaccines and therapeutics, today announced its mRNA drug discovery partnership with University Health Network (UHN), ranked first on a list of Canada's top 40 research hospitals by Research Infosource Inc. and within one of the world’s top 5 hospitals for the fourth year in a row, as reported by Newsweek. This collaboration will allProvidence Therapeutics Appoints Robert Georgantas, Ph.D. as President and Chief Technology Officer
CALGARY, Alberta, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Providence Therapeutics Holdings Inc. ("Providence"), a biopharmaceutical company developing messenger RNA (mRNA) vaccines and therapeutics, today announced the appointment of Robert Georgantas III, Ph.D., as President and chief technology officer (CTO).
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Providence Therapeutics
Sign Up For FreeTo access detailed company insights
Providence Therapeutics is a Canadian clinical-stage biotechnology company specializing in the development of mRNA vaccines and therapeutics aimed at treating cancer and infectious diseases. With operations in Calgary and Toronto, the company offers a robust ecosystem for the rapid development of mRNA-based solutions. Their platform technology is d... Read More
